OBD vs. COS, FUM, C4XD, DDDD, OKYO, SAR, AOR, OPTI, AREC, and RLM
Should you be buying Oxford BioDynamics stock or one of its competitors? The main competitors of Oxford BioDynamics include Collagen Solutions plc (COS.L) (COS), Futura Medical (FUM), C4X Discovery (C4XD), 4D pharma (DDDD), OKYO Pharma (OKYO), Sareum (SAR), AorTech International (AOR), OptiBiotix Health (OPTI), Arecor Therapeutics (AREC), and Realm Therapeutics (RLM). These companies are all part of the "biotechnology" industry.
Oxford BioDynamics vs.
Oxford BioDynamics (LON:OBD) and Collagen Solutions plc (COS.L) (LON:COS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation, community ranking and profitability.
Collagen Solutions plc (COS.L) has a net margin of 0.00% compared to Oxford BioDynamics' net margin of -1,800.32%. Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Oxford BioDynamics' return on equity.
In the previous week, Oxford BioDynamics' average media sentiment score of 0.75 beat Collagen Solutions plc (COS.L)'s score of 0.00 indicating that Oxford BioDynamics is being referred to more favorably in the media.
44.3% of Oxford BioDynamics shares are held by institutional investors. 16.8% of Oxford BioDynamics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Collagen Solutions plc (COS.L) received 25 more outperform votes than Oxford BioDynamics when rated by MarketBeat users. Likewise, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 60.47% of users gave Oxford BioDynamics an outperform vote.
Collagen Solutions plc (COS.L) has lower revenue, but higher earnings than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks.
Summary
Collagen Solutions plc (COS.L) beats Oxford BioDynamics on 6 of the 11 factors compared between the two stocks.
Get Oxford BioDynamics News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford BioDynamics Competitors List
Related Companies and Tools
This page (LON:OBD) was last updated on 4/20/2025 by MarketBeat.com Staff
Buy OBD Stock Free OBD Stock Alerts